233 related articles for article (PubMed ID: 21249158)
1. Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy.
VanGuilder HD; Bixler GV; Kutzler L; Brucklacher RM; Bronson SK; Kimball SR; Freeman WM
PLoS One; 2011 Jan; 6(1):e16271. PubMed ID: 21249158
[TBL] [Abstract][Full Text] [Related]
2. The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin.
Fort PE; Freeman WM; Losiewicz MK; Singh RS; Gardner TW
Mol Cell Proteomics; 2009 Apr; 8(4):767-79. PubMed ID: 19049959
[TBL] [Abstract][Full Text] [Related]
3. Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.
Bixler GV; Vanguilder HD; Brucklacher RM; Kimball SR; Bronson SK; Freeman WM
BMC Med Genomics; 2011 May; 4():40. PubMed ID: 21575160
[TBL] [Abstract][Full Text] [Related]
4. Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice.
Zhang SY; Li BY; Li XL; Cheng M; Cai Q; Yu F; Wang WD; Tan M; Yan G; Hu SL; Gao HQ
Mol Vis; 2013; 19():812-21. PubMed ID: 23592918
[TBL] [Abstract][Full Text] [Related]
5. Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy.
Quin G; Len AC; Billson FA; Gillies MC
Proteomics; 2007 Aug; 7(15):2636-50. PubMed ID: 17647246
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
[TBL] [Abstract][Full Text] [Related]
7. The role of insulin resistance in experimental diabetic retinopathy-Genetic and molecular aspects.
Järgen P; Dietrich A; Herling AW; Hammes HP; Wohlfart P
PLoS One; 2017; 12(6):e0178658. PubMed ID: 28575111
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina.
Adachi-Uehara N; Kato M; Nimura Y; Seki N; Ishihara A; Matsumoto E; Iwase K; Ohtsuka S; Kodama H; Mizota A; Yamamoto S; Adachi-Usami E; Takiguchi M
Exp Eye Res; 2006 Oct; 83(4):849-57. PubMed ID: 16780836
[TBL] [Abstract][Full Text] [Related]
9. In vivo retinal gene expression in early diabetes.
Joussen AM; Huang S; Poulaki V; Camphausen K; Beecken WD; Kirchhof B; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3047-57. PubMed ID: 11687554
[TBL] [Abstract][Full Text] [Related]
10. Functional changes in the neural retina occur in the absence of mitochondrial dysfunction in a rodent model of diabetic retinopathy.
Masser DR; Otalora L; Clark NW; Kinter MT; Elliott MH; Freeman WM
J Neurochem; 2017 Dec; 143(5):595-608. PubMed ID: 28902411
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes.
Gao BB; Phipps JA; Bursell D; Clermont AC; Feener EP
J Proteome Res; 2009 Dec; 8(12):5541-9. PubMed ID: 19845401
[TBL] [Abstract][Full Text] [Related]
12. Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Zhang Y; Wang Q; Zhang J; Lei X; Xu GT; Ye W
Graefes Arch Clin Exp Ophthalmol; 2009 May; 247(5):699-706. PubMed ID: 19084986
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
14. SWATH-MS Proteomic Analysis of Oxygen-Induced Retinopathy Reveals Novel Potential Therapeutic Targets.
Vähätupa M; Nättinen J; Jylhä A; Aapola U; Kataja M; Kööbi P; Järvinen TAH; Uusitalo H; Uusitalo-Järvinen H
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3294-3306. PubMed ID: 30025079
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
16. Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.
Van Hove I; De Groef L; Boeckx B; Modave E; Hu TT; Beets K; Etienne I; Van Bergen T; Lambrechts D; Moons L; Feyen JHM; Porcu M
Diabetologia; 2020 Oct; 63(10):2235-2248. PubMed ID: 32734440
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
18. BTBR ob/ob mouse model of type 2 diabetes exhibits early loss of retinal function and retinal inflammation followed by late vascular changes.
Lee VK; Hosking BM; Holeniewska J; Kubala EC; Lundh von Leithner P; Gardner PJ; Foxton RH; Shima DT
Diabetologia; 2018 Nov; 61(11):2422-2432. PubMed ID: 30094465
[TBL] [Abstract][Full Text] [Related]
19. Differential proteome analysis of serum proteins associated with the development of type 2 diabetes mellitus in the KK-A(y) mouse model using the iTRAQ technique.
Takahashi E; Okumura A; Unoki-Kubota H; Hirano H; Kasuga M; Kaburagi Y
J Proteomics; 2013 Jun; 84():40-51. PubMed ID: 23545169
[TBL] [Abstract][Full Text] [Related]
20. Diabetes Induced Alterations in Murine Vitreous Proteome Are Mitigated by IL-6 Trans-Signaling Inhibition.
Robinson R; Youngblood H; Iyer H; Bloom J; Lee TJ; Chang L; Lukowski Z; Zhi W; Sharma A; Sharma S
Invest Ophthalmol Vis Sci; 2020 Sep; 61(11):2. PubMed ID: 32870245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
